Clinical Trial Update: The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study of SHR3824 in healthy volunteers has completed, evaluating pharmacokinetics and pharmacodynamics for Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED